“…Casas R et al, [46] in their recent study evaluated inflammatory markers like high-sensitivity C-reactive protein (hs-CRP), the levels of main cytokines (IL-1 , 5, 6, 7, 8, 12, TNF-, and IFN-) and vulnerability plaque marker (IL-10, 13, and 18) levels. They showed an improvement of these parameters in people having high cardiovascular risk long-term adherence, treated with MeDiet supplemented with EVOO, suggesting a delay in atheroma plaque forma-tion [26,46,47]. Consumption of a Mediterranean-style diet supplemented with EVOO also in patients with the metabolic syndrome was associated a significant reduction of systemic vascular inflammation markers (IL-6, IL-7, IL-18, and hs-CRP) [48].…”